Cel-Sci Insider Trades
NYSE: CVMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 5 · $867.00K
- Sales
- 0 · $0
- Shares bought / sold
- 546.41K / 0
- Net activity
- Net buying $866,999
Cel-Sci insider activity
Over the last 12 months, Cel-Sci insiders reported 17 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $866,999 and sold $0 worth of stock, for net insider buying of $866,999. The most recent filing shows KERSTEN GEERT R (Chief Executive Officer) reporting a transaction in 2,621 shares at $2.06 on Sep 30, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CVM's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CVM insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 30, 2026 | PRICHEP PATRICIA BChief Financial Officer | Award | 2,082 | $4.29K | Form 4 |
| Sep 30, 2026 | TALOR EYALChief Scientific Officer | Award | 1,165 | $2.40K | Form 4 |
| Sep 30, 2026 | KERSTEN GEERT RChief Executive Officer | Award | 2,621 | $5.40K | Form 4 |
| Aug 25, 2026 | KERSTEN GEERT RChief Executive Officer | Buy | 100,000 | $138.00K | Form 4 |
| Jun 30, 2026 | KERSTEN GEERT RChief Executive Officer | Award | 5,192 | $5.40K | Form 4 |
| Jun 30, 2026 | PRICHEP PATRICIA BChief Financial Officer | Award | 4,125 | $4.29K | Form 4 |
| Jun 30, 2026 | TALOR EYALChief Scientific Officer | Award | 2,307 | $2.40K | Form 4 |
| May 14, 2026 | KERSTEN GEERT RChief Executive Officer | Buy | 300,000 | $360.00K | Form 4 |
| May 13, 2026 | KERSTEN GEERT RChief Executive Officer | Buy | 100,000 | $119.00K | Form 4 |
| Mar 31, 2026 | KERSTEN GEERT RChief Executive Officer | Award | 1,682 | $5.40K | Form 4 |
| Mar 31, 2026 | TALOR EYALChief Scientific Officer | Award | 747 | $2.40K | Form 4 |
| Mar 31, 2026 | PRICHEP PATRICIA BChief Financial Officer | Award | 1,336 | $4.29K | Form 4 |
| Jan 22, 2026 | KERSTEN GEERT RChief Executive Officer | Buy | 38,023 | $200.00K | Form 4 |
| Dec 31, 2025 | KERSTEN GEERT RChief Executive Officer | Award | 998 | $5.25K | Form 4 |
| Dec 31, 2025 | PRICHEP PATRICIA BChief Financial Officer | Award | 815 | $4.29K | Form 4 |
| Dec 31, 2025 | TALOR EYALChief Scientific Officer | Award | 456 | $2.40K | Form 4 |
| Dec 4, 2025 | KERSTEN GEERT RChief Executive Officer | Buy | 8,389 | $50.00K | Form 4 |
| Sep 30, 2025 | KERSTEN GEERT RChief Executive Officer | Award | 570 | $5.24K | Form 4 |
| Sep 30, 2025 | PRICHEP PATRICIA BChief Financial Officer | Award | 466 | $4.29K | Form 4 |
| Sep 30, 2025 | TALOR EYALChief Scientific Officer | Award | 260 | $2.39K | Form 4 |
| Jul 25, 2025 | KERSTEN GEERT RChief Executive Officer | Buy | 29,197 | $200.00K | Form 4 |
| Jul 25, 2025 | Watson Robert EugeneDirector | Buy | 2,919 | $20.00K | Form 4 |
| Jun 30, 2025 | KERSTEN GEERT RChief Executive Officer | Award | 2,292 | $5.25K | Form 4 |
| Jun 30, 2025 | TALOR EYALChief Scientific Officer | Award | 1,048 | $2.40K | Form 4 |
| Jun 30, 2025 | PRICHEP PATRICIA BChief Financial Officer | Award | 1,873 | $4.29K | Form 4 |
| Mar 31, 2025 | KERSTEN GEERT RChief Executive Officer | Award | 22,786 | $5.25K | Form 4 |
| Mar 31, 2025 | PRICHEP PATRICIA BChief Financial Officer | Award | 15,432 | $3.56K | Form 4 |
| Mar 31, 2025 | TALOR EYALChief Scientific Officer | Award | 10,416 | $2.40K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4